Junying I. Tang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
SHR-2004, a Humanized Monoclonal Antibody Targeting Factor XI, for Preventing Venous Thromboembolism After Ovarian Cancer Surgery: A Randomized, Active-Controlled Phase 2 Study.
Journal: American journal of hematology
Published: April 21, 2026
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
CircRNA14781 promotes olaparib resistance of ovarian cancer cells by regulating miR-330-5p/NGFR pathway.
Journal: Journal of ovarian research
Published: September 09, 2025
Comparing the KangDuo Surgical Robot-01 and da Vinci Xi system for endometrial cancer surgery: a multi-center, randomized, parallel-controlled, noninferiority trial.
Journal: International journal of surgery (London, England)
Published: March 21, 2025
Rapamycin reduces DNA damage of in vitro matured oocytes by promoting Rad51-mediated homologous recombination.
Journal: Reproductive biology and endocrinology : RB&E
Published: March 20, 2025
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: December 03, 2024
Cost-effectiveness of robotic surgery compared to conventional laparoscopy for the management of early-stage cervical cancer: a model-based economic evaluation in China.
Journal: BMJ open
Published: November 21, 2024
Economic evaluation of GnRH-agonist long protocol and GnRH-antagonist protocol in IVT/ICSI among the Chinese population: using pharmacoeconomic models.
Journal: BMJ open
Published: August 17, 2024
Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.
Journal: Medical oncology (Northwood, London, England)
Published: April 27, 2024
An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer.
Journal: Scientific reports
Published: January 04, 2024
Intraoperative implantation of 125I seeds improves prognosis in refractory stage IIIB cervical cancer: a case report and literature review.
Journal: BMC women's health
Published: October 20, 2023
Comparison of two 3D reconstruction models for understanding of complicated female pelvic tumors.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: June 05, 2023
Last Updated: 09/26/2026